ES2175413T5 - Formulaciones de aerosol - Google Patents

Formulaciones de aerosol

Info

Publication number
ES2175413T5
ES2175413T5 ES97925141T ES97925141T ES2175413T5 ES 2175413 T5 ES2175413 T5 ES 2175413T5 ES 97925141 T ES97925141 T ES 97925141T ES 97925141 T ES97925141 T ES 97925141T ES 2175413 T5 ES2175413 T5 ES 2175413T5
Authority
ES
Spain
Prior art keywords
formulation
aerosol formulations
polar
delivering
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97925141T
Other languages
English (en)
Other versions
ES2175413T3 (es
Inventor
Fiona C Millar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10797901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2175413(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ES2175413T3 publication Critical patent/ES2175413T3/es
Publication of ES2175413T5 publication Critical patent/ES2175413T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/141—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant specially adapted for specific contents or propellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44—Valves specially adapted for the discharge of contents; Regulating devices
    • B65D83/52—Metering valves; Metering devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
ES97925141T 1996-08-01 1997-06-03 Formulaciones de aerosol Expired - Lifetime ES2175413T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616237.5A GB9616237D0 (en) 1996-08-01 1996-08-01 Aerosol formulations
PCT/GB1997/001502 WO1998005302A1 (en) 1996-08-01 1997-06-03 Aerosol formulations

Publications (2)

Publication Number Publication Date
ES2175413T3 ES2175413T3 (es) 2002-11-16
ES2175413T5 true ES2175413T5 (es) 2016-05-26

Family

ID=10797901

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97925141T Expired - Lifetime ES2175413T5 (es) 1996-08-01 1997-06-03 Formulaciones de aerosol

Country Status (14)

Country Link
US (3) US7566445B1 (es)
EP (1) EP0918507B2 (es)
JP (2) JP4794701B2 (es)
AT (1) ATE215359T2 (es)
AU (1) AU721920B2 (es)
CA (1) CA2261879C (es)
DE (1) DE69711637T3 (es)
DK (1) DK0918507T4 (es)
ES (1) ES2175413T5 (es)
GB (1) GB9616237D0 (es)
NO (1) NO325491B1 (es)
NZ (1) NZ333986A (es)
PT (1) PT918507E (es)
WO (1) WO1998005302A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DK1121112T3 (da) * 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EE05167B1 (et) 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2011039196A1 (en) * 2009-09-29 2011-04-07 Helen Mary Trill Improvements to pressurised metered dose inhalers
EP3554127B1 (en) 2010-11-10 2020-09-09 Panasonic Intellectual Property Corporation of America Terminal and coding mode selection method
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3206667A1 (en) 2014-10-16 2017-08-23 Teva Branded Pharmaceutical Products R & D, Inc. Inhalable formulation
US10563361B2 (en) 2016-01-12 2020-02-18 Ch3 Solutions, Llc System and method for customizing a playing field

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US261539A (en) * 1882-07-25 Sap-pail cover and holder
BE555319A (es) * 1956-03-21 1900-01-01
BE556587A (es) 1957-01-31 1957-04-11
AT215359B (de) 1958-04-05 1961-05-25 Fleissner Gmbh Siebtrommeltrockner für Fasermaterial
GB8501015D0 (en) 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
ATE78158T1 (de) 1985-05-22 1992-08-15 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
JPH05505824A (ja) 1990-03-23 1993-08-26 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
AU650463B2 (en) 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
CA2083821A1 (en) 1990-06-28 1991-12-29 Keith A. Johnson Aerosol drug formulations
JP2854974B2 (ja) 1990-06-29 1999-02-10 フアイソンズ・ピーエルシー 加圧エアロゾル組成物
WO1992002287A1 (en) 1990-08-09 1992-02-20 Stokes, Jack, A. Oil reclaiming device
US5115803A (en) * 1990-08-31 1992-05-26 Minnesota Mining And Manufacturing Company Aerosol actuator providing increased respirable fraction
ATE114112T1 (de) * 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
GB9024365D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
US6503482B1 (en) 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
PT656206E (pt) 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
WO1992022286A1 (en) 1991-06-12 1992-12-23 Minnesota Mining And Manufacturing Company Albuterol sulfate suspension aerosol formulations
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressurised aerosol compositions
DE4132176C2 (de) 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
JP3026841B2 (ja) 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
DK0717987T3 (da) 1991-12-18 2001-11-12 Minnesota Mining & Mfg Suspension-aerosol-formuleringer
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
US5376359A (en) 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
ES2129117T3 (es) 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
JPH0780069A (ja) 1993-09-13 1995-03-28 Otsuka Pharmaceut Co Ltd プロカテロールを含有するエアゾール製剤
EP0735884B1 (en) * 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5635159A (en) 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
JP4155594B2 (ja) 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
CA2218179A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
GB9610341D0 (en) 1996-05-17 1996-07-24 Andaris Ltd Formulation for inhalation
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
WO1998024420A1 (en) 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Pharmaceutical compositions and devices for their administration
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
GB2332372B (en) 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
ES2141049B1 (es) 1998-03-11 2000-10-16 Aldo Union S A Lab Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
ID27887A (id) 1998-04-18 2001-05-03 Glaxo Group Ltd Formulasi aerosol farmasi
ATE253896T1 (de) 1998-06-18 2003-11-15 Boehringer Ingelheim Pharma Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ATE234604T1 (de) 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
US6136294C1 (en) 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
PL196413B1 (pl) 1999-02-05 2007-12-31 Cipla Ltd Kompozycja lecznicza, dozownik zawierający kompozycję leczniczą, sposób przygotowania dozownika i zastosowanie kompozycji
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19924098A1 (de) 1999-05-26 2000-12-07 Boehringer Ingelheim Pharma Edelstahlkanister für treibgasbetriebene Dosieraerosole
CN1144582C (zh) 2000-11-28 2004-04-07 中国药科大学 治疗呼吸系统疾病的无氟里昂药用气雾剂
EP1486563A4 (en) 2002-02-27 2008-01-09 Yasumitsu Nagao EMBRYONALLY MODIFIED ANIMAL AND METHOD OF CONSTRUCTING THEM
JP4527949B2 (ja) 2003-06-24 2010-08-18 ニプロパッチ株式会社 粘着テープ

Also Published As

Publication number Publication date
JP2000515536A (ja) 2000-11-21
NZ333986A (en) 1999-05-28
US20090246148A1 (en) 2009-10-01
US20140326759A1 (en) 2014-11-06
US7566445B1 (en) 2009-07-28
DK0918507T3 (da) 2002-07-29
JP2011173910A (ja) 2011-09-08
DE69711637T2 (de) 2002-11-28
US9650203B2 (en) 2017-05-16
NO990454L (no) 1999-03-29
EP0918507A1 (en) 1999-06-02
ES2175413T3 (es) 2002-11-16
DE69711637T3 (de) 2016-04-28
NO325491B1 (no) 2008-05-19
JP4794701B2 (ja) 2011-10-19
CA2261879A1 (en) 1998-02-12
AU3038197A (en) 1998-02-25
CA2261879C (en) 2006-10-03
DK0918507T4 (en) 2016-03-14
AU721920B2 (en) 2000-07-20
PT918507E (pt) 2002-09-30
NO990454D0 (no) 1999-01-29
GB9616237D0 (en) 1996-09-11
EP0918507B2 (en) 2015-12-09
EP0918507B1 (en) 2002-04-03
US8834849B2 (en) 2014-09-16
ATE215359T2 (de) 2002-04-15
DE69711637D1 (de) 2002-05-08
WO1998005302A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DE69711637D1 (de) Aerosolformulierungen
CA2125665A1 (en) Medicaments
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
NO972781L (no) Aerosolformuleringer av peptider og proteiner
MY118151A (en) Pharmaceutical formulations containing voriconazole.
YU59192A (sh) Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
ES2150022T3 (es) Aerosol farmaceutico que contiene al menos un azucar.
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
DK1123120T3 (da) Medicinsk aerosolformulering
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
AU1534501A (en) Pharmaceutical formulations of salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.
IT1254453B (it) Composizioni farmaceutiche per uso orale a base di glutatione ridotto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 918507

Country of ref document: ES